4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, R; Bruce, C; Kentroti, S; Lee, K; Vernadakis, A	1

Other Studies

1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells. Journal of neuroscience research, 1991, Volume: 28, Issue:4 Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Astrocytes; Bucladesine; Glioma; Glutamate-Ammonia Ligase; Indicators and Reagents; Neoplasm Proteins; Phenotype; Phosphodiesterase Inhibitors; Platelet Activating Factor; Rats; Tumor Cells, Cultured	1991

Article

Year

Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells.

Journal of neuroscience research, 1991, Volume: 28, Issue:4

Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Astrocytes; Bucladesine; Glioma; Glutamate-Ammonia Ligase; Indicators and Reagents; Neoplasm Proteins; Phenotype; Phosphodiesterase Inhibitors; Platelet Activating Factor; Rats; Tumor Cells, Cultured

1991